Results 51 to 60 of about 643,233 (285)

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Artificial intelligence in project management: A bibliometric analysis [PDF]

open access: yesProblems and Perspectives in Management
This study explores the integration of artificial intelligence (AI) into project management through a bibliometric analysis of scholarly publications and patents from 2001 to 2024.
Nurkhat Ibadildin   +6 more
doaj   +1 more source

Culturally conditioned visual communication in creative expression

open access: yesCreativity Studies, 2020
The human body and its consciousness interacts with a number of external and internal factors, including, among others, the surrounding environment, experienced emotions, those things seen, things that are possessed and touched, and affection that is ...
Ilona Valantinaitė   +2 more
doaj   +1 more source

Adapting, surviving, discovering: Creative practitioners in the COVID-19 crisis

open access: yesJournal of Creativity, 2022
This study investigates how the COVID-19 pandemic affected the work and creative practice of individuals who identify as artists, producers or makers.
Valeria Duarte, David Gauntlett
doaj   +1 more source

The London Creative Industries [PDF]

open access: yes, 2008
This lecture draws from the Creative Industries Observatory research on the London creative industries and in particular provides some initial insights into the networks and relationships which exist including organisational structure, size, and location.
Roodhouse, Simon
core  

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

The construction of everyday creative identity

open access: yesJournal of Creativity
Exploring everyday creative identity is important because everyday creators are often recognized as problem solvers whose fluency and flexibility influences those in their networks.
Mary Kay Culpepper, David Gauntlett
doaj   +1 more source

A Report on the Design Sub-Sector in London [PDF]

open access: yes, 2008
Housed in the School of Creative Enterprise at the London College of Communication (University of the Arts), the Creative Industries Observatory (CIO) is a leading contributor to academic research and analysis within the creative industries, and a source
Cardoso, Eva   +7 more
core  

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy